Phobia (Neurophysiology)

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Phobia (Neurophysiology).php on line 2
Phobia (Neurophysiology)

LE WE PMID CA

Phobia (Neurophysiology)

3121

Angst (Neurophysiologie)

Aggression (Neurophysiology)

Alcohol

Amygdala

Autism

Cognitive behavior therapy

Cognitive enhancer

D Cycloserine

Depression

Duloxetine

Emotion (Neurophysiology)

Endocannabinoid

Escitalopram

Ghrelin

Hippocampus

Learning and memory (Neurophysiology)

Neuropeptide S

Neuropeptide Y

Obsessive compulsive disorder

Periaquaeductal gray

Phobia (Neurophysiology)

Post traumatic stress disorder

Prefrontal cortex

Pregabalin

Quetiapine

Stress (Neurophysiology)

Yohimbine

2003 1	Generalized anxiety disorder. [12938785] South Med J 96(6): 581-6 (2003)
1999 2	Anxiety disorders in children and adolescents. [10548164] South Med J 92(10): 946-54 (1999)
2001 3	Rages and refusals. Managing the many faces of adolescent anxiety. [11398717] Can Fam Physician 47(-): 1023-30 (2001)
1994 4	Anxiety disorders in family practice. Diagnosis and management. [8312758] Can Fam Physician 40(-): 81-8 (1994)
1993 5	Anxiety disorders. Part 1: Diagnosis and treatment. [8219867] Can Fam Physician 39(-): 2194-8; 2201 (1993)
1993 6	Anxiety disorders. Part 2: Pharmacotherapy with benzodiazepines. [8106034] Can Fam Physician 39(-): 2205-8; 2211-3 (1993)
1993 7	Anxiety disorders. Focus on obsessive-compulsive disorder. [8348022] Can Fam Physician 39(-): 1612-21 (1993)
2002 8	Fear knot. Neurobiological disruption of long-term fear memory. [11872508] Br J Psychiatry 180(-): 195-7 (2002)
2009 9	The functional neuroanatomy of dread: Functional magnetic resonance imaging insights into generalized anxiety disorder and its treatment. [19255044] Am J Psychiatry 166(3): 263-5 (2009)
2007 10	Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. [17898336] Am J Psychiatry 164(10): 1476-88 (2007)
2007 11	Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. [17267793] Am J Psychiatry 164(2): 290-300 (2007)
2003 12	Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? [12900305] Am J Psychiatry 160(8): 1432-8 (2003)
2000 13	Neuroanatomical hypothesis of panic disorder, revised. [10739407] Am J Psychiatry 157(4): 493-505 (2000)
1998 14	Panic and phobic anxiety: defining phenotypes for genetic studies. [9734536] Am J Psychiatry 155(9): 1152-62 (1998)
1998 15	Panic and phobic anxiety: phenotypes, endophenotypes, and genotypes. [9734534] Am J Psychiatry 155(9): 1147-9 (1998)
2009 16	High anxieties: the social construction of anxiety disorders. [19660164] Can J Psychiatry 54(7): 429-36 (2009)
2006 17	Clinical practice guidelines. Management of anxiety disorders. [16933543] Can J Psychiatry 51(8 Suppl 2): 9S-91S (2006)
2000 18	Childhood anxiety disorders: lessons from the literature. [11086555] Can J Psychiatry 45(8): 724-30 (2000)
1997 19	Developments in anxiety disorders. [9469233] Can J Psychiatry 42(10): 1015-6 (1997)
2008 20	Relaxation training for anxiety: a ten-years systematic review with meta-analysis. [18518981] BMC Psychiatry 8(-): 41 (2008)
2006 21	Predicting danger: the nature, consequences, and neural mechanisms of predictive fear learning. [16741278] Learn Mem 13(3): 245-53 (2006)
2004 22	Emotional perseveration: an update on prefrontal-amygdala interactions in fear extinction. [15466303] Learn Mem 11(5): 525-35 (2004)
2009 23	Duloxetine for the treatment of generalized anxiety disorder: a review. [19557096] Neuropsychiatr Dis Treat 5(-): 23-31 (2009)
2008 24	New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine. [19337458] Neuropsychiatr Dis Treat 4(6): 1181-91 (2008)
2008 25	The role of duloxetine in the treatment of anxiety disorders. [19183783] Neuropsychiatr Dis Treat 4(5): 929-35 (2008)
2008 26	Pharmacotherapy of panic disorder. [19043522] Neuropsychiatr Dis Treat 4(4): 779-95 (2008)
2007 27	The therapeutic potential of escitalopram in the treatment of panic disorder. [19300618] Neuropsychiatr Dis Treat 3(6): 835-8 (2007)
2007 28	The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic. [19300556] Neuropsychiatr Dis Treat 3(2): 237-43 (2007)
2006 29	Experimental animal models for the simulation of depression and anxiety. [17117614] Dialogues Clin Neurosci 8(3): 323-33 (2006)
2006 30	Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. [17227287] CNS Drug Rev 12(3-4): 208-17 (2006)
2007 31	Modulation of fear and anxiety by the endogenous cannabinoid system. [17329982] CNS Spectr 12(3): 211-20 (2007)
2007 32	Clinical perspectives on the combination of D-cycloserine and cognitive-behavioral therapy for the treatment of anxiety disorders. [17192764] CNS Spectr 12(1): 51-6, 59-61 (2007)
2006 33	Efficacy of combined pharmacotherapy and psychotherapy versus monotherapy in the treatment of anxiety disorders. [17008828] CNS Spectr 11(10 Suppl 12): 29-33 (2006)
2006 34	Understanding the neurobiology of comorbidity in anxiety disorders. [17008826] CNS Spectr 11(10 Suppl 12): 13-20 (2006)
2006 35	Recent advances in the understanding and treatment of anxiety disorders. Resilience: determinants, measurement, and treatment responsiveness. [17008825] CNS Spectr 11(10 Suppl 12): 5-12 (2006)
2004 36	Generalized anxiety disorder: acute and chronic treatment. [15448583] CNS Spectr 9(10): 716-23 (2004)
2009 37	The pharmacologic treatment of patients with generalized anxiety disorder: where are we now and where are we going? [19238125] CNS Spectr 14(2 Suppl 3): 5-12 (2009)
1997 38	Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex. [9415919] Philos Trans R Soc Lond B Biol Sci 352(1362): 1675-87 (1997)
2004 39	Panic disorder: psychopathology, medical management and dental implications. [15270162] J Am Dent Assoc 135(6): 771-8; quiz 796-7 (2004)
2003 40	Anatomical connections of the periaqueductal gray: specific neural substrates for different kinds of fear. [12715074] Braz J Med Biol Res 36(5): 557-66 (2003)
2003 41	Pharmacology of human experimental anxiety. [12700819] Braz J Med Biol Res 36(4): 421-32 (2003)
2001 42	The brain decade in debate: II. Panic or anxiety? From animal models to a neurobiological basis. [11175489] Braz J Med Biol Res 34(2): 145-54 (2001)
2009 43	The anxiety disorder spectrum: fear imagery, physiological reactivity, and differential diagnosis. [19096959] Anxiety Stress Coping 22(1): 5-25 (2009)
2010 44	Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. [20393190] Physiol Rev 90(2): 419-63 (2010)
2002 45	A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety. [12433315] Health Technol Assess 6(22): 1-89 (2002)
2011 46	Anxiety disorders - assessment and management in general practice. [21655481] Aust Fam Physician 40(6): 370-4 (2011)
2008 47	Panic disorder. [19445787] Clin Evid (Online) 2008(-): - (2008)
2010 48	Erasing fear memories with extinction training. [21068303] J Neurosci 30(45): 14993-7 (2010)
2005 49	Neuropeptide S: a new player in the modulation of arousal and anxiety. [15731503] Mol Interv 5(1): 42-6 (2005)
2010 50	Prefrontal control of fear: more than just extinction. [20303254] Curr Opin Neurobiol 20(2): 231-5 (2010)
2010 51	Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety. [20881320] Exp Biol Med (Maywood) 235(10): 1163-7 (2010)
2011 52	Current management of obsessive and phobic states. [22003299] Neuropsychiatr Dis Treat 7(-): 599-610 (2011)
2002 53	The biology of fear- and anxiety-related behaviors. [22033741] Dialogues Clin Neurosci 4(3): 231-49 (2002)
2002 54	Psychopharmacology of anxiety disorders. [22033867] Dialogues Clin Neurosci 4(3): 271-85 (2002)
2002 55	Nonpharmacological treatments for anxiety disorders. [22034140] Dialogues Clin Neurosci 4(3): 305-19 (2002)
2010 56	Neural systems underlying approach and avoidance in anxiety disorders. [21319496] Dialogues Clin Neurosci 12(4): 517-31 (2010)
2010 57	Behavioral and neural analysis of GABA in the acquisition, consolidation, reconsolidation, and extinction of fear memory. [20410874] Neuropsychopharmacology 35(8): 1625-52 (2010)
2010 58	The neurocircuitry of fear, stress, and anxiety disorders. [19625997] Neuropsychopharmacology 35(1): 169-91 (2010)
2010 59	Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. [19693004] Neuropsychopharmacology 35(1): 105-35 (2010)
2010 60	Changing fear: the neurocircuitry of emotion regulation. [19710632] Neuropsychopharmacology 35(1): 136-46 (2010)
2010 61	Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders--the case of yohimbine. [20036429] Trends Pharmacol Sci 31(1): 2-7 (2010)
2007 62	Elevated mazes as animal models of anxiety: effects of serotonergic agents. [17401477] An Acad Bras Cienc 79(1): 71-85 (2007)
2003 63	Panic disorder in children and adolescents. [12619196] Yonsei Med J 44(1): 174-9 (2003)
2007 64	The extinction of conditioned fear: structural and molecular basis and therapeutic use. [17435934] Rev Bras Psiquiatr 29(1): 80-5 (2007)
2008 65	Structural magnetic resonance imaging in anxiety disorders: an update of research findings. [18833427] Rev Bras Psiquiatr 30(3): 251-64 (2008)
2010 66	Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. [19836379] Eur J Pharmacol 626(1): 49-56 (2010)
2010 67	Molecular specificity of multiple hippocampal processes governing fear extinction. [20458884] Rev Neurosci 21(1): 1-17 (2010)
2010 68	Glutamate plasticity in the drunken amygdala: the making of an anxious synapse. [20813244] Int Rev Neurobiol 91(-): 205-33 (2010)
2007 69	Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. [17726478] Nat Neurosci 10(9): 1116-24 (2007)
2010 70	Temperament and the environment in the etiology of childhood anxiety. [20158575] J Child Psychol Psychiatry 51(4): 497-517 (2010)
2009 71	Neuroimaging in anxiety disorders. [18568288] J Neural Transm 116(6): 703-16 (2009)
2011 72	Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis. [21735077] Clin Child Fam Psychol Rev 14(3): 302-17 (2011)
2008 73	Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. [18363421] J Clin Psychiatry 69(4): 621-32 (2008)
2011 74	Fear or disgust? The role of emotions in spider phobia and blood-injection-injury phobia. [21638233] Turk Psikiyatri Derg 22(2): 115-22 (2011)
2010 75	Continuing the search for the engram: examining the mechanism of fear memories. [20569648] J Psychiatry Neurosci 35(4): 221-8 (2010)
2010 76	Neuropeptide S: a transmitter system in the brain regulating fear and anxiety. [19523478] Neuropharmacology 58(1): 29-34 (2010)
2005 77	Overview of diagnosis and drug treatments of anxiety disorders. [15618947] CNS Spectr 10(1): 49-56 (2005)
2005 78	The role of glutamate in anxiety and related disorders. [16400245] CNS Spectr 10(10): 820-30 (2005)
2011 79	Neural mechanisms of impaired fear inhibition in posttraumatic stress disorder. [21845177] Front Behav Neurosci 5(-): 44 (2011)
2010 80	Aggression and anxiety: social context and neurobiological links. [20407578] Front Behav Neurosci 4(-): 12 (2010)
2010 81	Interoception in anxiety and depression. [20490545] Brain Struct Funct 214(5-6): 451-63 (2010)
2008 82	Anxiety in dementia: a critical review. [18555569] Clin Psychol Rev 28(7): 1071-82 (2008)
2008 83	Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders. [17532105] Clin Psychol Rev 28(2): 199-210 (2008)
2008 84	Models and mechanisms of anxiety: evidence from startle studies. [18058089] Psychopharmacology (Berl) 199(3): 421-37 (2008)
2010 85	Ghrelin's Roles in Stress, Mood, and Anxiety Regulation. [20721341] Int J Pept 2010(-): - (2010)
2010 86	Early prevention in childhood anxiety disorders. [21131407] Am J Psychiatry 167(12): 1428-30 (2010)
2011 87	Cognitive enhancers for anxiety disorders. [21134394] Pharmacol Biochem Behav 99(2): 275-84 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Phobia (Neurophysiology).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Phobia (Neurophysiology).php on line 92